Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GC Innovation America is the U.S.-based innovation and investment arm historically associated with PTT Global Chemical and the former Myriant business. The company develops and commercializes biobased chemical technologies, particularly organic acids and derivative products made from renewable feedstocks, and also participates in strategic technology scouting and investment activities for the broader GC group. Its legacy technical work has included succinic acid fermentation technology and related downstream products for materials and chemical applications rather than human therapeutics. Although it has exposure to biotech and life science investing, GC Innovation America is primarily an industrial biotechnology and sustainable materials company, not a drug-development biotech. The business appears active, with corporate continuity under PTTGC ownership and later legal naming tied to GC America Sustainability Corporation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GC Innovation America.